COMPARE · Data as of August 28, 2026
HOOD vs IX
Verdict: Side-by-side breakdown using the Bull Rankings model. HOOD scored 77.0, IX scored 76.0 — HOOD leads.
Compare another set
HOOD
Robinhood Markets, Inc.
53.2Fin
$109.76 · $98.7B
fundamentals as of
Strength gap
14.5
IX leads
IX
ORIX Corporation
67.7Fin
$39.00 · $42.4B
At a glance · who leads each dimension, on the model's own rules
- CheapestIX11.0x
- Fastest growthHOOD+51.6%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
Fundamentals, head-to-head
HOOD
IX
+51.6%A
Rev
+18.6%B+
48.1xD
P/E
11.0xB+
23.6%A-
ROE
—
10.41D
P/B
—
0.0%C
Yield
—
—
D/E
1.30C+
—
PEG
2.72C
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
HOODRobinhood Markets, Inc.
Why now
Capital Markets · market cap $98.7b. Down 29% from 52-week high of $153.86 — deep drawdown territory. Revenue growing +52% — in hypergrowth territory. 26 sell-side analysts rate this a Buy with a mean 1-yr target of $120.08 (implying +9% upside).
Moat
Net margin 42% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. $98.7b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
D/E 2.40 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Beta 2.32 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Trailing P/E 48x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
IXORIX Corporation
Why now
Financial Conglomerates · market cap $42.4b. 8% off the 52-week high of $42.39. Revenue growing +19%, comfortably above the S&P median.
Moat
Net margin 18% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 14% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.